Doyugan, Katherine D.

HRN: 19-29-29  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/23/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/23/2025
12/25/2025
IVTT
900mg
Q8h
Elective D&C
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines